NCT00660647 - Optimized Treatment Algorithm for Patients With Early Rheumatoid Arthritis (RA) | Biotech Hunter

Enrollment

180

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions

Arthritis, Rheumatoid

Interventions

DRUG

Adalimumab

Adalimumab injection 0.8 ml (40 mg) s.c. every second week in up to 2 years

DRUG

Placebo

Saline injection 0.9%, 0.8 ml s.c. every second week up to 2 years

Trial Locations (1)

Aarhus University Hospital, Aarhus